Umbilical Cord Blood
8
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia
Performance Evaluation of the ex Utero Cord Blood Collection Technique: Procedure, Quality and Results
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
Umbilical Cord Blood Treatment for Refractory Immune Cytopenia
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure